BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28741726)

  • 1. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.
    Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A
    Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression.
    Huo J; Zhang A; Guo X; Qiang H; Liu P; Bai L; Ma A
    Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):851-61. PubMed ID: 27199074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G604S-hERG mutation alters the biophysical properties and exerts a dominant-negative effect on expression of hERG channels in HEK293 cells.
    Huo J; Zhang Y; Huang N; Liu P; Huang C; Guo X; Jiang W; Zhou N; Grace A; Huang CL; Ma A
    Pflugers Arch; 2008 Aug; 456(5):917-28. PubMed ID: 18386051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
    Casis O; Olesen SP; Sanguinetti MC
    Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
    Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
    Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
    Li P; Chen X; Zhang Q; Zheng Y; Jiang H; Yang H; Gao Z
    J Pharmacol Exp Ther; 2014 Dec; 351(3):596-604. PubMed ID: 25232191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.
    Guo J; Cheng YM; Lees-Miller JP; Perissinotti LL; Claydon TW; Hull CM; Thouta S; Roach DE; Durdagi S; Noskov SY; Duff HJ
    Biophys J; 2015 Mar; 108(6):1400-1413. PubMed ID: 25809253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells.
    Schuster AM; Glassmeier G; Bauer CK
    Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
    Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
    Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model.
    Peitersen T; Grunnet M; Benson AP; Holden AV; Holstein-Rathlou NH; Olesen SP
    Heart Rhythm; 2008 May; 5(5):734-41. PubMed ID: 18452879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological study of V535M hERG mutation of LQT2.
    Shao C; Lu Y; Liu M; Chen Q; Lan Y; Liu Y; Lin M; Li Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):741-748. PubMed ID: 22173492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
    Xu X; Recanatini M; Roberti M; Tseng GN
    Mol Pharmacol; 2008 Jun; 73(6):1709-21. PubMed ID: 18372399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
    Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
    Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
    Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
    Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
    Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
    J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
    Gianulis EC; Trudeau MC
    J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.
    Bilet A; Bauer CK
    PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel C-terminus frameshift mutation, 1122fs/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation.
    Sasano T; Ueda K; Orikabe M; Hirano Y; Kawano S; Yasunami M; Isobe M; Kimura A; Hiraoka M
    J Mol Cell Cardiol; 2004 Dec; 37(6):1205-11. PubMed ID: 15572050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms.
    Puckerin A; Aromolaran KA; Chang DD; Zukin RS; Colecraft HM; Boutjdir M; Aromolaran AS
    Heart Rhythm; 2016 May; 13(5):1121-1130. PubMed ID: 26775140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.